M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in vitro and in vivo
- 1 April 2016
- journal article
- Published by Elsevier in Translational Research
- Vol. 170, 99-111
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60 AR062755)
- NIH—NCATS (UL1 TR000062)
- South Carolina COBRE (P30 GM103342)
This publication has 42 references indexed in Scilit:
- The Structural Basis of Peptide-Protein Binding StrategiesStructure, 2010
- Synthetic therapeutic peptides: science and marketDrug Discovery Today, 2010
- Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosisRheumatology International, 2009
- Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificityNature Immunology, 2003
- Hepatocyte growth factor counteracts transforming growth factor‐β 1 , through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized miceThe FASEB Journal, 2002
- CD44 is required for two consecutive steps in HGF/c-Met signalingGenes & Development, 2002
- Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.2002
- The Semaphorin 4D receptor controls invasive growth by coupling with MetNature Cell Biology, 2002
- Platelet formation is the consequence of caspase activation within megakaryocytesBlood, 2002
- A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive GrowthCell, 2001